Serum levels of hsa‐miR‐16‐5p , hsa‐miR‐29a‐3p , hsa‐miR‐150‐5p , hsa‐miR‐155‐5p and hsa‐miR ‐ 223‐3p and subsequent risk of chronic lymphocytic leukemia in the EPIC study-Reference-Cited by-同舟云学术

Serum levels of hsa‐miR‐16‐5p , hsa‐miR‐29a‐3p , hsa‐miR‐150‐5p , hsa‐miR‐155‐5p and hsa‐miR ‐ 223‐3p and subsequent risk of chronic lymphocytic leukemia in the EPIC study

Published:2020-03-02 Issue:5 Volume:147 Page:1315-1324
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Casabonne Delphine¹²^ORCID,Benavente Yolanda¹²,Seifert Julia³,Costas Laura²,Armesto María³,Arestin María³,Besson Caroline⁴⁵⁶^ORCID,Hosnijeh Fatemeh S.⁷⁸^ORCID,Duell Eric J.⁹^ORCID,Weiderpass Elisabete¹⁰^ORCID,Masala Giovanna¹¹,Kaaks Rudolf¹²,Canzian Federico¹³,Chirlaque María‐Dolores¹¹⁴,Perduca Vittorio⁴⁵⁶¹⁵,Mancini Francesca R.⁴⁵^ORCID,Pala Valeria¹⁶,Trichopoulou Antonia¹⁷,Karakatsani Anna¹⁷¹⁸,La Vecchia Carlo¹⁷¹⁹^ORCID,Sánchez Maria‐Jose¹²⁰²¹,Tumino Rosario²²,Gunter Marc J.²³,Amiano Pilar¹²⁴,Panico Salvatore²⁵,Sacerdote Carlotta²⁶^ORCID,Schmidt Julie A.²⁷^ORCID,Boeing Heiner²⁸,Schulze Matthias B.²⁹³⁰,Barricarte Aurelio¹³¹³²,Riboli Elio³³,Olsen Anja³⁴,Tjønneland Anne³⁴³⁵,Vermeulen Roel⁷,Nieters Alexandra³⁶,Lawrie Charles H.³³⁷³⁸,Sanjosé Silvia¹²³⁹

Affiliation:

1. Centro de Investigación Biomédica en Red: Epidemiología y Salud Pública (CIBERESP) Madrid Spain

2. Unit of Molecular and Genetic Epidemiology in Infections and Cancer Catalan Institute of Oncology (ICO‐IDIBELL) Barcelona Spain

3. Molecular Oncology Group Biodonostia Research Institute San Sebastián Spain

4. CESP, Faculté de Médecine, Université Paris‐Sud, UVSQ, INSERM Université Paris‐Saclay Villejuif France

5. Gustave Roussy Villejuif France

6. Department of Hematology and Oncology Hospital of Versailles Le Chesnay France

7. Institute for Risk Assessment Sciences, Division of Environmental Epidemiology Utrecht University Utrecht The Netherlands

8. Department of Immunology, Laboratory Medical Immunology, Erasmus MC University Medical Center Rotterdam The Netherlands

9. Unit of Nutrition and Cancer, Cancer Epidemiology Research Program Catalan Institute of Oncology (ICO‐IDIBELL), L'Hospitalet de Llobregat Barcelona Spain

10. International Agency for Research on Cancer, World Health Organization Lyon France

11. Cancer Risk Factors and Life‐Style Epidemiology Unit Institute for Cancer Research, Prevention and Clinical Network ‐ ISPRO Florence Italy

12. Division of Cancer Epidemiology German Cancer Research Center (DKFZ) Heidelberg Germany

13. Genomic Epidemiology Group German Cancer Research Center (DKFZ) Heidelberg Germany

14. Department of Epidemiology, Regional Health Council, IMIB‐Arrixaca Murcia University Murcia Spain

15. Laboratoire de Mathématiques Appliquées MAP5 (UMR CNRS 8145) Université Paris Descartes Paris France

16. Epidemiology and Prevention Unit Fondazione IRCCS Istituto Nazionale dei Tumori di Milano Milan Italy

17. Hellenic Health Foundation Athens Greece

18. Pulmonary Medicine Department, School of Medicine National and Kapodistrian University of Athens, "ATTIKON" University Hospital Haidari Greece

19. Dept. of Clinical Sciences and Community Health Università Degli Studi di Milano Milan Italy

20. Andalusian School of Public Health (EASP) Granada Spain

21. Instituto de Investigación Biosanitaria de Granada (ibs.GRANADA) Universidad de Granada Granada Spain

22. Cancer Registry and Histopathology Department Azienda Sanitaria Provinciale (ASP) Ragusa Italy

23. Section of Nutrition and Metabolism IARC, International Agency for Research on Cancer Lyon France

24. Public Health Division of Gipuzkoa BioDonostia Research Institute San Sebastian Spain

25. Dipartimento di Medicina Clinica e Chirurgia Federico II University Naples Italy

26. Unit of Cancer Epidemiology Città Della Salute e Della Scienza University‐Hospital and Center for Cancer Prevention (CPO) Turin Italy

27. Cancer Epidemiology Unit, Nuffield Department of Population Health University of Oxford Oxford United Kingdom

28. Department of Epidemiology German Institute of Human Nutrition (DIfE) Postdam‐Rehbrücke Nuthetal Germany

29. Department of Molecular Epidemiology German Institute of Human Nutrition Potsdam‐Rehbruecke Nuthetal Germany

30. Institute of Nutritional Sciences University of Potsdam Nuthetal Germany

31. Navarra Public Health Institute Pamplona Spain

32. Navarra Institute for Health Research (IdiSNA) Pamplona Spain

33. School of Public Health Imperial College London London United Kingdom

34. Danish Cancer Society Research Center Copenhagen Denmark

35. Department of Public Health The Copenhagen University Copenhagen Denmark

36. Institute for Immunodeficiency (IFI) Faculty of Medicine and Medical Center University of Freiburg Freiburg Germany

37. Radcliffe Department of Medicine University of Oxford, John Radcliffe Hospital Oxford United Kingdom

38. IKERBASQUE Basque Foundation for Science Bilbao Spain

39. Reproductive Health, PATH Seattle WA

Funder

Agència de Gestió d'Ajuts Universitaris i de Recerca

Cancer Research UK

Kræftens Bekæmpelse

Deutsche Krebshilfe

European Commission

Bundesministerium für Bildung und Forschung

Deutsches Krebsforschungszentrum

Institut National de la Santé et de la Recherche Médicale

Centre International de Recherche sur le Cancer

Ligue Contre le Cancer

Medical Research Council Canada

European Regional Development Fund

Cancerfonden

World Cancer Research Fund

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.32894

Reference49 articles.

1. Survival for haematological malignancies in Europe between 1997 and 2008 by region and age: results of EUROCARE-5, a population-based study

2. Cell proliferation and death: Forgotten features of chronic lymphocytic leukemia B cells

3. Monoclonal B-Cell Lymphocytosis and Chronic Lymphocytic Leukemia

4. Increased frequency (12%) of circulating chronic lymphocytic leukemia–like B-cell clones in healthy subjects using a highly sensitive multicolor flow cytometry approach

5. MicroRNAs and haematology: small molecules, big function

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Integrative investigation of hematotoxic effects induced by low doses of lead, cadmium, mercury and arsenic mixture: In vivo and in silico approach;Science of The Total Environment;2024-06

2. miRNA Biology in Chronic Lymphocytic Leukemia;Seminars in Hematology;2024-06

3. Circulating miR-16 and miR-21 Levels in Multiple Myeloma: Prognostic Significance of Survival and Response to Lenalidomide Treatment;International Journal of Molecular Sciences;2024-05-31

4. An overview of prognostic markers in patients with CLL;Frontiers in Oncology;2024-05-16

5. miR-155 and miR-223 as markers of biological and clinical features of chronic lymphocytic leukemia;Siberian journal of oncology;2024-03-22